Related Experiment Video
Updated: Jul 19, 2026
10:28
Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Parkinson's disease: background, diagnosis, and initial management
1Geriatrics Research, Education, and Clinical Center, Veterans Administration Medical Center, Ann Arbor, MI 48109-0585, USA. ralbin@umich.edu
Clinics in Geriatric Medicine
|September 27, 2006
Summary
Parkinson's disease is a common neurodegenerative disorder affecting the elderly. This review covers its clinical features, diagnosis, and initial management strategies for this disabling movement disorder.
Area of Science:
- Neurology
- Geriatrics
- Movement Disorders
Background:
- Parkinson's disease is a prevalent neurodegenerative condition linked to aging.
- It is the second most common movement disorder in older adults, following essential tremor.
- Parkinson's disease represents the leading cause of disabling movement disorders.
Purpose of the Study:
- To provide a comprehensive overview of Parkinson's disease.
- To detail the primary clinical manifestations and diagnostic approaches.
- To outline the initial management strategies for patients with Parkinson's disease.
Main Methods:
- Literature review of Parkinson's disease.
- Synthesis of clinical features, diagnostic criteria, and treatment guidelines.
- Focus on the elderly population and disabling aspects.
Main Results:
- Detailed description of cardinal clinical features of Parkinson's disease.
- Discussion on differential diagnosis to distinguish from other movement disorders.
- Outline of a systematic approach to diagnosis.
- Recommendations for initial therapeutic interventions.
Conclusions:
- Accurate diagnosis and timely initial management are crucial for patients with Parkinson's disease.
- Understanding clinical features aids in differentiating Parkinson's disease from other conditions.
- This review provides a foundation for managing Parkinson's disease in the elderly.
Related Concept Videos
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:11Alterations in Muscle Tone lll
Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...